Cost effectiveness of multiple sclerosis drugs remains unknownBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7258.399/a (Published 12 August 2000) Cite this as: BMJ 2000;321:399
View Full Text
- Rhona MacDonald
No single drug used in the treatment of multiple sclerosis has been shown to be better than any other despite the huge differences in cost, a recent review has found. Drugs range in annual cost from £18 ($27) (for methotrexate) to £20 000 …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.